Investigative Ophthalmology & Visual Science Cover Image for Volume 41, Issue 10
September 2000
Volume 41, Issue 10
Free
Retinal Cell Biology  |   September 2000
Expression of Somatostatin Subtype 1 Receptor in the Rabbit Retina
Author Affiliations
  • Rosella Cristiani
    From the Dipartimento di Fisiologia e Biochimica “G. Moruzzi,” Università di Pisa, Italy;
  • Gigliola Fontanesi
    From the Dipartimento di Fisiologia e Biochimica “G. Moruzzi,” Università di Pisa, Italy;
  • Giovanni Casini
    Dipartimento di Scienze Ambientali, Università della Tuscia, Viterbo, Italy; and
  • Cristina Petrucci
    From the Dipartimento di Fisiologia e Biochimica “G. Moruzzi,” Università di Pisa, Italy;
  • Cecile Viollet
    Institut National de la Santé et de la Recherche Médicale, Paris, France.
  • Paola Bagnoli
    From the Dipartimento di Fisiologia e Biochimica “G. Moruzzi,” Università di Pisa, Italy;
Investigative Ophthalmology & Visual Science September 2000, Vol.41, 3191-3199. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rosella Cristiani, Gigliola Fontanesi, Giovanni Casini, Cristina Petrucci, Cecile Viollet, Paola Bagnoli; Expression of Somatostatin Subtype 1 Receptor in the Rabbit Retina. Invest. Ophthalmol. Vis. Sci. 2000;41(10):3191-3199.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

purpose. To detect mRNAs for somatostatin (somatotropin release-inhibiting factor [SRIF]) receptor subtypes 1 to 5 (sst1 through sst5) in rabbit retinas by reverse transcription–polymerase chain reaction (RT-PCR) and to investigate the distribution of sst1 by single- and double-label immunocytochemistry.

methods. Semiquantitative RT-PCR using sst-specific primers from mouse sequences was performed. sst1 was localized using a polyclonal antiserum directed to human sst1 in cryostat sections of retinas from either normal or optic nerve–transected animals. Immunolabeled cell sizes and densities were measured in wholemounted retinas using computer-assisted image analysis. Double-label immunofluorescence was performed using the sst1 antiserum in conjunction with monoclonal antibodies directed to SRIF, tyrosine hydroxylase (TH), parvalbumin (PV), or γ-aminobutyric acid (GABA).

results. With RT-PCR it was found that all five sst mRNAs were expressed in the rabbit retina, with highest levels of sst1 mRNA. sst1 immunolabeling was localized to amacrine cells in the proximal inner nuclear layer (INL) of all retinal regions and to displaced amacrine cells in the ganglion cell layer (GCL) of the ventral retina. Some large sst1-immunoreactive (IR) somata were also present in the GCL. They were not observed after optic nerve transection. Double-label immunofluorescence showed sst1 expression by all TH-IR amacrine cells and by other amacrine cells that were neither PV-IR nor GABA-IR. In addition, sst1 was expressed by all SRIF-containing displaced amacrine cells.

conclusions. All five sst mRNAs are expressed in the rabbit retina. The localization of sst1 suggests that it may mediate SRIF actions onto amacrine (including dopaminergic) and sparse ganglion cells. sst1 expression in SRIF-IR cells suggests that this receptor may also act as an autoreceptor.

Somatotropin release-inhibiting factor (SRIF) is a neurotransmitter and a neuromodulator in the central nervous system. 1 2 Five different ssts have been cloned and designated sst1 through sst5. 3 Although there is a high degree of sequence and structural homology among different ssts, they differ in their pharmacologic and functional properties. 4 For instance, sst1 and sst2 differ in their affinity to specific SRIF agonists and in their modes of transmembrane signaling. 4 Both sst1 and sst2 are coupled to inhibition of adenylate cyclase (AC), but sst2, and not sst1, internalizes or desensitizes after exposure to the agonist. 4 These diversities may underlie different functional roles of the two receptors. In particular, although both sst1 and sst2 are involved in regulation of growth hormone secretion, 5 sst1 may also act as an autoreceptor and inhibit SRIF release. 6 In addition, activation of sst1 increases nerve cell responses to glutamate (GLU), whereas activation of sst2 results in a decrease of GLU sensitivity. 7 Moreover, sst2, but not sst1, has been reported to regulate Ca2+ influx through voltage-gated Ca2+ channels. 8  
SRIF cell populations have been reported in a variety of vertebrate retinas. 9 10 11 12 13 In the rabbit, SRIF is expressed by sparse displaced amacrine cells in the ganglion cell layer (GCL) of the ventral retina. In spite of low cellular density of SRIF somata, SRIF processes extensively arborize in the inner plexiform layer (IPL) of all retinal regions, which suggests that SRIF may influence several cell types by acting at multiple levels of the retinal circuitry. 12 14 15 16  
SRIF influences on retinal function are poorly understood. In the rabbit retina, SRIF has been shown to influence the spontaneous firing of retinal ganglion cells (GCs) and induce modifications in their receptive fields. 17 In the rat retina, SRIF has been suggested to modulate γ-aminobutyric acid (GABA)-ergic transmission through phosphorylation of GABAA receptors. 18 In the avian retina, SRIF may participate in a dark–light switch operating through inhibition of dopamine (DA) release. 19 Both in avian and in rat retinas, SRIF appears to be positively coupled to AC, which is surprising, because ssts are generally thought to be negatively coupled to AC. 18 20  
To get a deeper insight into SRIF functions, data on the retinal localization of specific ssts are needed. Of the two sst2 isoforms, sst2A has been immunohistochemically localized in rabbit 21 22 and in rat 23 24 retinas. In rabbits, it is expressed mainly by rod bipolar cells and by sparse amacrine cells. These amacrines have been reported to have no tyrosine hydroxylase (TH)-immunoreactivity (IR) 21 or to partially express 22 TH-IR. In the rat retina, sst2A has been localized to amacrine cells, including TH-IR amacrine cells, to rod and cone bipolar cells, and to horizontal cells. 23 24 sst1 expression has been investigated in rat retinas, where it can be observed in SRIF-expressing and displaced amacrine cells, as well as in rare GCs. 23 Information on the localization of sst1 in rabbits is needed to complete our understanding of sst2A and sst1 expression in rabbit and rat retinas and to inquire about possible species-specific functional roles of sst2A and sst1 in the retinas of rats and rabbits. 
In the present investigation, we first used reverse transcription–polymerase chain reaction (RT-PCR) to determine the relative levels of the five different sst mRNAs in the rabbit retina and found that sst1 mRNA is the most abundantly expressed. Subsequently, both single- and double-label immunohistochemistry was performed to investigate the cellular expression pattern of sst1 in rabbit retinas. 
Methods
Animals and Tissue Preparation
New Zealand albino rabbits were used in compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Rabbits were deeply anesthetized with 30% chloral hydrate in sterile saline (intraperitoneally, 1.0 ml/kg; Sigma, St. Louis, MO). For PCR analysis, retinas were dissected in RNase-free conditions and stored at− 80°C. For immunohistochemical experiments, both retinal sections and whole retinas were used. Retinas were immersion fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (PB; pH 7.4) for 2 hours. They were cryoprotected with 25% sucrose in 0.1 M PB, and sections were cut either perpendicular or parallel to the vitreal surface at 12 to 15 μm with a cryostat, mounted onto gelatin-coated slides, and stored at −20°C. Alternatively, whole retinas were frozen and thawed, treated with 2.3% sodium metaperiodate in distilled water and subsequently with 1% sodium borohydride in 0.25 M Tris buffer before immunocytochemical staining. 
Optic Nerve Transection
Rabbits were deeply anesthetized with a mixture of medetomidine (intraperitoneally, 0.5 ml/kg; Domitor; Farmos, Turku, Finland) and Ketamine hydrochloride (1 ml/kg; Inoketam; Virbac, Carros, France). The optic nerve was transected after a procedure described by Rickman et al. 12 Surgery was performed under sterile conditions, and National Institutes of Health guidelines were observed. Briefly, after local infiltration of procaine (Novocain; Angelini, Rome, Italy) in the lateral canthus of anesthetized rabbits, the eye was pulled forward, and the optic nerve was exposed. It was then transected approximately 2 mm behind the sclera. After 120-day survival, retinas were fixed, and the completeness of the optic nerve transection was assessed. 
Semiquantitative RT-PCR Analysis
Total RNAs were extracted from six rabbit retinas in guanidine hydrochloride by using a kit (Simple Nucleic Acid Preparation; Invitrogen, Leek, The Netherlands). Cyclophilin B mRNA was used as an internal standard. 25 26 First-strand cDNA for PCR was generated from 1 μg of total RNA. Reverse transcription was performed according to Viollet et al. 27 One tenth of the RT product was amplified in a total volume of 50 μl using 1.5 U Taq polymerase. 27 Each sst mRNA was coamplified with cyclophilin B mRNA. Amplification was performed in an automatic thermocycler (Hybaid, Teddington, UK) beginning with a denaturation step at 94°C for 30 seconds, followed by 26 cycles of 94°C for 15 seconds, 60°C for 30 seconds, and 72°C for 15 seconds. The reaction was terminated with a 10-minute extension at 72°C. 
Nucleotide sequences of rabbit sst genes are not known. Therefore, for amplification, sense primers were chosen among mouse sequences. The sequence of the primers are given in Table 1 . The reverse primer sequence common to all ssts (COM 2) was chosen in the very conserved seventh transmembrane domain. 27 Cyclophilin B primers were chosen according to the mouse sequence. 32 COM 2 and cyclophilin reverse primers were 5′-end labeled with [32P] adenosine triphosphate (NEN, Boston, MA) by using T4 polynucleotide kinase (Boehringer–Mannheim, Mannheim, Germany). 
For each amplification, two types of controls were performed: an RT-PCR mixture with no reverse transcriptase to control genomic DNA contamination and a PCR mixture with no cDNA template, added to check for possible external contamination. 
A 10-μl sample of the PCR reaction was electrophoresed on a 8% polyacrylamide gel (Bio-Rad, Hercules, CA). After migration, the gel was dried and exposed to film (X-O-MAT; Eastman Kodak, Rochester, NY). Bands corresponding to the amplified products (characterized on the basis of their molecular weights) were cut and counted in aβ -scintillation counter (LKB, Wallac, Finland). 
The values, expressed as amount of recovered radioactivity, are relative to the cyclophilin B mRNA level (SRIF receptor mRNA/cyclophilin B mRNA). A semilogarithmic plot of recovered radioactivity versus cycle number showed an exponential increase in the PCR amplification between cycles 23 and 29 followed by a plateau. Curves of cyclophilin B and SRIF receptor mRNA amplification were parallel. All the conditions were chosen in the linear part of the coamplification. The cDNA from mouse pituitary, which express sst1 to 5, was used as a positive control (Petrucci et al., unpublished result, 1999). 
Immunohistochemistry
A rabbit polyclonal antibody directed to the carboxyl-terminal sequence of human sst1 33 was used (kindly provided by Lone Helboe, University of Copenhagen, Denmark). It has been used to study sst1 distribution in the rat hypothalamus 6 and retina. 23 In rat retinas, Western blot analysis showed no cross-reactivity of sst1 antiserum with other ssts. 23  
The dilutions of primary and of secondary antibodies reported herein were established in pilot experiments or were in accordance with previous studies. 12 34 35  
Cryostat sections were incubated with the sst1 antiserum (1:5000) in 0.1 M PB containing 1% Triton X-100 overnight at 4°C. Sections were washed in 0.1 M PB and incubated with indocarbocyanine (Cy3)-conjugated sheep anti-rabbit IgG (1:100; Sigma) and the slides coverslipped with mounting medium (Vectashield; Vector, Burlingame, CA). Alternatively, after incubation with the primary antibody, sections were incubated in biotinylated goat anti-rabbit IgG (1:50; Vector) and subsequently in an avidin-biotin-peroxidase mixture (ABC; Vectastain ABC Kit, Vector), both for 2 hours at room temperature. Sections were then treated with 0.05% 3,3′-diaminobenzidine tetrahydrochloride (DAB) and 0.03% hydrogen peroxide (H2O2), dehydrated, and coverslipped with Permount (BDH; Poole, Dorset, UK). Wholemount preparations were incubated with the sst1 antiserum (1:2000) in 0.25 M Tris buffer containing 10% normal goat serum and 1% Triton X-100 for 3 to 4 days at 4°C. After incubation in biotinylated goat anti-rabbit IgG (1:50; Vector) for 2 days at 4°C, retinas were treated with ABC (2 days at 4°C). DAB and H2O2 treatment followed. Retinas were then mounted GCL up, dehydrated, and coverslipped with Permount. 
Specificity of the immune reaction was assessed by using either the preimmune serum or the primary antibody preadsorbed with 10−5 M sst1 synthetic peptide overnight at 4°C in place of the primary antibody. Unspecific staining was observed in photoreceptor outer segments in cells that resembled microglial cells located in the IPL and in the GCL and in rare somata in the distal inner nuclear layer (INL) and in the outer plexiform layer (OPL). 
In double-labeling experiments, the sst1 antiserum was used in conjunction with a rat monoclonal antibody directed to SRIF (1:50; Chemicon, Temecula, CA), or with mouse monoclonal antibodies directed to TH (1:100; Boehringer–Mannheim), parvalbumin (PV; 1:1000; Sigma), or GABA (1:200; Sigma). Cryostat sections were washed in 0.1 M PB and incubated in 0.1 M PB with 0.1% Triton X-100 containing both the sst1 antiserum (1:5000) and one of the four specified antibodies overnight at 4°C. In addition, double-labeling experiments were performed using the TH monoclonal antibody in conjunction with a guinea pig polyclonal antiserum directed to GABA (NT108, 1:750, Eugene Tech, Allendale, NJ). After incubation with the primary antibodies, sections were incubated in the presence of the appropriate affinity-purified secondary IgGs conjugated with either fluorescein isothiocyanate (FITC; 1:50, Vector) or Cy3 (1:100, Sigma) for 2 hours at room temperature. Sections were then washed in 0.1 M PB and coverslipped with mounting medium (Vectashield; Vector). To eliminate the possibility of cross-reaction between primary and secondary antibodies in double-labeling experiments, control sections were made by omitting either of the primary antibodies. Control experiments were also performed to ensure that the primary antibodies did not cross-react when mixed together and that the secondary antibodies reacted only with the appropriate antigen-antibody complex. 36 Finally, the preadsorbed sst1 antiserum (see above) was used in conjunction with normal mouse serum in place of SRIF, TH, PV, or GABA monoclonal antibodies. 
Immunofluorescent materials were observed with both conventional fluorescence and confocal microscopy. 
Figure Preparation
Bright-field images were acquired at 300 dots per inch (DPI) using a digital imaging system (DC 100; Leica, Bensheim, Germany). Both bright-field images and electronic images from the confocal microscope were processed by computer (PhotoShop, ver. 5.0; Adobe, Mountain View, CA). 
Quantitative Analysis of Wholemount Preparations
Mean soma diameter and density (expressed as cells per square millimeter) of sst1-IR cells were measured in three wholemounts originating from different animals to account for the variations in the number and the density of immunostained cells. 37 Measurements of sst1-IR cells were performed in 10,000-μm2 fields at different sample locations regularly spaced throughout the retina. Thirty to 40 locations were analyzed in each retina. Details of the procedure for quantitative analysis have been published previously. 34 35 38 Quantitative data were obtained using a computer-assisted image analysis system that included a microscope (Axioplan; Carl Zeiss, Oberkochen, Germany) equipped with a color CCD video camera (JVC TK 1280E; SDS, Cambridge, MA), interfaced with a computer-assisted image analyzer. The software package for quantitative image analysis (Optimas 6.1; Media Cybernetics, Silver Spring, MD) included a routine for automatic counts of immunolabeled profiles and morphometric analysis. In the measurements, no correction for shrinkage was applied, because retinas were attached to the slides before dehydration. 39 Estimations of absolute numbers of immunolabeled cells (cells per retina) were obtained by multiplying the mean cell density times the area of the retina. In the case of sst1-IR putative displaced amacrine cells, the cell density was multiplied times the area of the ventral retina, because these cells were observed only in the ventral retina, as will be described later. Values of mean diameter, cell density, and absolute cell number are expressed as means ± SEM of the measurements in the three retinas analyzed. 
Results
RT-PCR Analysis
RT-PCR analysis using primers based on mouse sequences detected sst mRNAs in rabbit retinas. Positive controls (mouse pituitary) confirmed the specificity of the results. As shown in Figure 1A , RT-PCR on both mouse pituitary and rabbit retina samples yielded amplified products at 66 bp (sst1), 78 bp (sst2), 87 bp (sst3), 69 bp (sst4), and 363 bp (sst5). As shown in Figure 1B , sst1 mRNA appeared to be highly expressed in the rabbit retina, whereas moderate to low levels of sst2, sst3, and sst4 mRNAs were observed. Finally, sst5 mRNA was only slightly above the detection level. 
sst1 Immunostaining Patterns
sst1 immunolabeling was mostly observed to outline the plasma membrane of somata in the INL adjacent to the IPL (Figs. 2A , 2B) . sst1-IR cells are also localized to the GCL. They were characterized by either small or large soma size (Fig. 2B) . The small-sized immunolabeled somata in the GCL were observed only in ventral retinal regions. The large-sized immunostained cells were sparsely distributed throughout the retina. In retinal sections treated with the avidin-biotin-peroxidase technique, sst1-IR fibers appeared to be scattered in the IPL, and we could not associate them with specific IPL laminae. However, with confocal microscopy these fibers appeared to be confined to laminae 1 and 5 (according to Cajal 40 ) of the IPL, with immunolabeling often observed also in lamina 3. These fibers originated from cell bodies located in the inner INL (Fig. 3A ) and in the GCL (Fig. 3B) . These observations are consistent with the expression of sst1 in amacrines, displaced amacrines and, possibly, GCs. 
Both in wholemount preparations and in horizontal sections through the INL, two different types of amacrine cells could be detected, based on their soma size, in all retinal regions (Fig. 4A ). The first type was represented by cell bodies with mean diameter of 12.6 ± 2.3 μm and with sparse distribution throughout the retina (mean density 15.52 ± 3.82 cells/mm2). An estimate of their absolute number is 6200 ± 1200 cells/retina. These immunolabeled somata gave rise to two to three thick primary processes that arborized in varicose collaterals. The second type of sst1-IR amacrine cell was characterized by oval to round soma shapes, by apparent absence of immunostained processes, and by mean soma diameters of 8.9 ± 2.8 μm. These cells were densely distributed in all retinal regions with a mean density of 112.24 ± 24.68 cells/mm2 and a mean absolute number of 56,700 ± 800 cells/retina. 
In the GCL, sst1-IR cells were likely to be both displaced amacrines and GCs (Fig. 4B) . With the assumption that immunolabeled somata with soma sizes similar to those of amacrine cells in the INL were displaced amacrines, whereas those with larger somata were GCs, we performed a separate analysis for these two distinct cell groups in the GCL. Putative sst1-IR GCs had mean soma diameters of 18.3 ± 4.0 μm and a sparse distribution throughout the retina with a mean density of 2.71 ± 0.90 cells/mm2 and a mean absolute number of 1000 ± 110 cells/retina. Bundles of sst1-IR processes were observed in the GC axon layer. The dendritic arbors of putative sst1-IR GCs were poorly immunolabeled, and only the proximal portion of primary processes could be detected (Fig. 4B) . After optic nerve transection, sst1 immunolabeling in the GCL was restricted to small sized sst1-IR somata, and sst1-IR putative GCs were no longer observed. 
Putative sst1-IR displaced amacrines had a mean soma diameter of 14.3 ± 3.8 μm, were characterized by ovoid or multipolar soma shapes, and were almost exclusively observed in ventral retinal regions. They originated thick primary processes that arborized into a meshwork of fine varicose fibers in laminae 1 and 5 of the IPL (Figs. 5A , 5B) distributed in all retinal regions. Their mean absolute number amounted to 1700 ± 120 cells/retina. Their densities, measured at three retinal eccentricities in the ventral retina, are shown in Figure 5C . These cells were sparsely distributed along the visual streak (4.57 ± 1.40 cells/mm2) and in midperipheral retina (5.14 ± 1.35 cells/mm2), whereas their highest density was observed at the ventral retinal edge (12.14 ± 2.91 cells/mm2). 
Double-Labeling Experiments
Both the quantitative and the morphologic features of the first population of sst1-IR amacrine cells were in the range of those previously reported for the population of TH-IR amacrine cells in adult rabbit retinas. 34 41 42 43 In addition, the distribution of sst1-IR processes in laminae 1, 3, and 5 of the IPL was similar to that of processes of TH-IR amacrine cells. Therefore, double-labeling experiments were performed using the sst1 antiserum in conjunction with an antibody directed to TH. As shown in Figure 6 , TH-IR amacrines also expressed sst1, both on their cell bodies and on their processes. All the TH-IR amacrine cells were also labeled with the sst1 antiserum, and all the large-sized sst1-IR amacrines were TH-IR. 
The size and the shapes of immunolabeled cell bodies belonging to the second population of sst1-IR amacrine cells resembled those of AII amacrine cell somata, that can be identified with antibodies directed to PV. 35 As shown in Figures 7A and 7C , double-label immunofluorescence using the sst1 antiserum in conjunction with a PV antibody failed to show sst1 expression in PV-IR amacrines. We also observed that sst1-IR cells did not constitute a subset of GABAergic amacrine cells, because GABA-IR somata did not display sst1 immunoreactivity (Figs. 7B 7D) . Because a colocalization of GABA and TH has been reported in rat retinas, 44 we also tested the possible occurrence of GABA in TH-IR amacrine cells of rabbit retinas. In agreement with previous findings, 45 our results confirm that, in rabbits, TH-IR amacrines did not contain detectable GABA immunoreactivity (not shown). 
The unique localization of displaced sst1-IR amacrines to the GCL of the ventral retina, their sparse distribution, and the presence of sst1-IR processes in laminae 1 and 5 of the IPL suggests these cells are SRIF-displaced amacrines. Double-labeling experiments with sst1 antiserum in conjunction with an antibody directed to SRIF demonstrated coexpression of both SRIF and sst1 immunoreactivities in the same population of displaced amacrine cells. All the sst1-IR putative displaced amacrines also displayed SRIF immunoreactivity, and all the SRIF-IR somata were also labeled by sst1 antibodies (Figs. 8A , 8B)
Discussion
The present results established the presence of all five sst mRNAs in the rabbit retina as well as expression and localization of sst1 in populations of amacrines, displaced amacrines, and GCs. 
SRIF Receptor mRNAs
Semiquantitative RT-PCR showed the presence of all five sst mRNAs in the rabbit retina, indicating that rabbit sst mRNAs can be identified by RT-PCR methods using sst-specific primers based on mouse sequences. SRIF receptors have been cloned in human, rat, and mouse, and their sequences are highly conserved. 46 47 In particular, nucleotide sequence identity between human and rat ssts ranges from 97% for sst1 to 81% for sst5, 46 and amino acid sequences display a greater than 90% identity between the same sst in different species. 1 In addition, a recent RT-PCR analysis of sst mRNAs in guinea pig tissues has demonstrated close homology between the guinea pig and the human and rat sequences. 48 In our experiments, the RT-PCR gels of rabbit retinas produced results identical with those of mouse pituitary, suggesting that rabbit sst mRNAs possess a sufficient homology with mouse sst mRNAs to be detected with RT-PCR. 
The presence of sst2A mRNA has been recently demonstrated in the rat retina with RT-PCR. 24 In addition, a previous RT-PCR study reported the presence of sst mRNAs in rat ocular tissues and identified sst2 mRNA as the most abundantly expressed sst mRNA in the rat retina, followed by moderate levels of sst1, sst3, and sst4 and by low levels of sst5 mRNAs. 49 In contrast, our observations of the rabbit retina indicated high levels of sst1 mRNA, moderate levels of sst2 mRNA, and low to very low levels of sst3, sst4, and sst5 mRNAs. These differences may reflect different levels of expression of the various sst mRNAs in rat and rabbit retinas. However, the amount of sst mRNAs does not necessarily correlate with comparable levels of expressed proteins, because different messenger-to-protein ratios may result from differential posttranscriptional regulation of ssts. 
Localization of sst1
The present study reports a detailed analysis of the distribution of sst1 in the rabbit retina. The sst1 antiserum used in this investigation has been characterized, 33 and it has been used to localize sst1 in the rat hypothalamus 6 and retina. 23 It has also been used recently to confirm the decrease in sst1 expression in the rat hypothalamus after sst1 antisense treatment. 5 In our experiments, this antiserum specifically recognized sst1 expressed by amacrines, displaced amacrines, and GCs in rabbit retinas. 
The observed sst1 expression in TH-IR amacrines indicates that SRIF may participate in the control of dopaminergic cell functions (see below). TH-IR amacrine cells make extensive synaptic contacts with AII amacrine cells, 35 thereby influencing the flow of visual information through the rod pathway. The presence of sst1 in TH-IR amacrines may indicate an indirect influence of SRIF in the modulation of the rod pathway at the level of AII amacrine cells. Possible direct SRIF effects on AII amacrines would not be mediated by sst1, because there was no absence of sst1 expression in PV-IR amacrines, which include AII amacrine cells. 35  
Regarding the numerous sst1-expressing, non–TH-IR amacrines, quantitative studies of the rabbit retina confirmed that a large majority of all amacrine cells contain either glycine or GABA. 50 Because sst1-IR unidentified amacrines are not AII- or GABA-containing cells, they may constitute a subpopulation of glycinergic amacrine cells different from AII amacrines. Consistent with our findings, in the rat retina sst1 is not expressed by glutamate decarboxylase-IR amacrines. 23  
One discrete population of displaced amacrine cells in the rabbit retina is represented by SRIF displaced amacrines. 12 These cells are characterized by the expression of sst1 which is therefore likely to function as an autoreceptor. Similar observations have been recently reported in rat retinas. 23 Further evidence for sst1 as an autoreceptor is provided by its localization on SRIF neurons of the rat hypothalamus. 6  
sst1-IR large-sized somata in the GCL are likely to be GCs, as indicated by the absence of sst1-IR putative GCs after optic nerve transection. The observation of sst1 expression in a small number of GCs is consistent with recent data on sst1 expression in the rat retina. 23 As shown by quantitative measurements, sst1-IR GCs seem to comprise a very sparse group. However, the possibility exists that we have underestimated the population of sst1-IR GCs, because the amount of immunolabeled fiber bundles in the GC axon layer would indicate a higher number of sst1-IR GCs. 
Functional Implications
In the rabbit retina, exogenous SRIF enhances the signal-to-noise ratio and shifts the center-surround balance of GCs. 17 Although some GCs express sst1, the observed SRIF effects on GC physiology are likely to result from complex functional interactions involving different ssts and different retinal cell types. For instance, SRIF has been reported to inhibit Ca2+ influx in rod bipolar cells of both goldfish 51 and rat 52 retinas. In addition, in the salamander retina, SRIF has been shown to reduce the Ca2+ current of rod photoreceptors but to increase that of cone photoreceptors. 53 The sst2A isoform is expressed by rod bipolar cells in rat 24 and in rabbit 21 22 retinas and by rod and cone photoreceptors in the salamander retina. 53 In addition, sst2 has been reported to mediate the SRIF-induced inhibition of Ca2+ influx in cultured cells (for a review see Reference 8). These observations suggest that the reported SRIF-induced modulation of Ca2+ currents in bipolar cells and in rod and cone photoreceptors is mediated by the sst2A isoform. Thus, sst2A may mediate a possible SRIF control of glutamate (GLU) release in both photoreceptors and bipolar cells. 
SRIF effects mediated by sst1 were confined to innermost retinal portions, and, as discussed, involved two different populations of amacrine cells (one of which is represented by TH-IR amacrines), the SRIF displaced amacrines, and some GCs. Regarding possible actions of SRIF onto dopaminergic cells, potent stimulatory effects of SRIF on DA release in the rat striatum have been reported 54 ; however, this effect seems to be mediated by sst2. 55 SRIF control of dopaminergic amacrines is likely both in rat and in rabbit retinas, but rat and rabbit clearly differ in the specific sst that mediates control. Whereas in rat retinas dopaminergic amacrines express sst2A but not sst1, 23 in rabbit retinas TH-IR amacrines seem not to express 21 or to express only partially 22 sst2A, whereas they express sst1. It is interesting to note that the effects of SRIF on rabbit GCs are similar to dark adaptation, 17 whereas DA, with an extracellular level that increases with increasing ambient light intensity, is involved in light adaptation. 56 As previously suggested, 17 SRIF may be released in the dark and, therefore, it may act through sst1 on rabbit dopaminergic amacrines as a dark signal, resulting in inhibition of DA release. This is consistent with observations of the chicken retina where amacrine cells coexpressing enkephalin, neurotensin, and SRIF are active in the dark and inhibit dopaminergic amacrines. 19 In contrast, in rat retinas, SRIF action on dopaminergic amacrines through sst2A could stimulate DA release, as in the rat striatum. 55 This hypothesis suggests different mechanisms for dark–light adaptation in rat and in rabbit retinas that may be related to the remarkable differences in diurnal activity patterns of rats and rabbits. Functional data on the effects of SRIF in the rat retina would shed some light on this issue. 
As a final consideration, we may observe that among rodent species there are differences in the molecular forms of SRIF that are expressed in the retina. Indeed, whereas in rat retinas only SRIF-14 is detected, 57 rabbit retinas display a content of SRIF-28 that is approximately 10% of total SRIF 17 58 and, in mouse retinas, SRIF-binding sites display greater specificity for SRIF-28 than for SRIF-14. 59 It is conceivable that differences in the organization of somatostatinergic systems are present in retinas of closely related species, and these differences may be reflected at various levels, including preferential expression of a particular molecular form of SRIF and species-specific patterns of expression of ssts. 
 
Table 1.
 
Primers Used for Amplification
Table 1.
 
Primers Used for Amplification
Sense primers
sst1 (M1i) CAAGACGACGCCACCGTGAGCCA 28
sst2 (M2i) ATCAGCCCCACCCCAGCCCTGAA 28
sst3 (M3i) GTGTGCCCGCTGCCGGAGGAGCC 29
sst4 (M4i) ACCAGCCTCGATGCCACTGTCAA 30
sst5 (M5) GGGCTGGGGCACCTGCAACCTGA 27 31
Cyclophilin B CCATCGTGTCATCAAGGACTTCAT 32
Reverse primers
COM2 GGGGTTGGCACAGCTGTTG 27
Cyclophilin B TTGCCATCCAGCCAGGAGGTCT 32
Figure 1.
 
(A) RT-PCR products in homogenates from rabbit retinas (lanes a) and from mouse pituitary (lanes b, positive controls). Mouse subtype-specific primers yielded products with identical molecular weights, corresponding to sst1 to sst5, in rabbit retinas and in mouse pituitary (66 bp for sst1, 78 bp for sst2, 87 bp for sst3, 69 bp for sst4, and 363 bp for sst5). Lane MW: Molecular weight markers. (B) Levels of SRIF receptor mRNAs in rabbit retinas as evaluated by RT-PCR semiquantitative analysis. Each histogram represents the mean ± SEM (n = 6) of SRIF receptor mRNA levels expressed as percentages of the cyclophilin B mRNA level.
Figure 1.
 
(A) RT-PCR products in homogenates from rabbit retinas (lanes a) and from mouse pituitary (lanes b, positive controls). Mouse subtype-specific primers yielded products with identical molecular weights, corresponding to sst1 to sst5, in rabbit retinas and in mouse pituitary (66 bp for sst1, 78 bp for sst2, 87 bp for sst3, 69 bp for sst4, and 363 bp for sst5). Lane MW: Molecular weight markers. (B) Levels of SRIF receptor mRNAs in rabbit retinas as evaluated by RT-PCR semiquantitative analysis. Each histogram represents the mean ± SEM (n = 6) of SRIF receptor mRNA levels expressed as percentages of the cyclophilin B mRNA level.
Figure 2.
 
sst1 immunostaining pattern in cryostat sections cut in a plane perpendicular to the vitreal surface and stained with the avidin-biotin peroxidase technique. (A, B) Most sst1-IR somata were located in the INL adjacent to the IPL. In addition, some sst1-IR cell bodies of either small or large size (B) were observed in the GCL. Dense immunolabeling is observed in the IPL. Light, unspecific immunolabeling is present in rare cell bodies in the distal INL and in the OPL. Scale bar, 20 μm.
Figure 2.
 
sst1 immunostaining pattern in cryostat sections cut in a plane perpendicular to the vitreal surface and stained with the avidin-biotin peroxidase technique. (A, B) Most sst1-IR somata were located in the INL adjacent to the IPL. In addition, some sst1-IR cell bodies of either small or large size (B) were observed in the GCL. Dense immunolabeling is observed in the IPL. Light, unspecific immunolabeling is present in rare cell bodies in the distal INL and in the OPL. Scale bar, 20 μm.
Figure 3.
 
Confocal images (0.5 μm thick) through sections cut in a plane perpendicular to the vitreal surface showing sst1 immunoreactivity as visualized with Cy3-conjugated secondary antibodies. Immunostained cell bodies were localized in the proximal INL (A) and in the GCL (B). Note the localization of sst1 immunoreactivity to the plasma membrane of the cell bodies and to processes confined to laminae 1, 3, and 5 (A) or to laminae 1 and 5 of the IPL (B). Scale bar, 30 μm.
Figure 3.
 
Confocal images (0.5 μm thick) through sections cut in a plane perpendicular to the vitreal surface showing sst1 immunoreactivity as visualized with Cy3-conjugated secondary antibodies. Immunostained cell bodies were localized in the proximal INL (A) and in the GCL (B). Note the localization of sst1 immunoreactivity to the plasma membrane of the cell bodies and to processes confined to laminae 1, 3, and 5 (A) or to laminae 1 and 5 of the IPL (B). Scale bar, 30 μm.
Figure 4.
 
Photomicrographs of retinal sections cut in a plane parallel to the vitreal surface and treated with the avidin-biotin-peroxidase technique. (A) shows large (arrow) and small (arrowhead) sst1-IR somata in the INL. Processes of these cells are not visible because the section was cut through the INL with no IPL portions included. (B) Large and small immunolabeled somata in the GCL with immunolabeled proximal portions of primary processes and bundles of sst1-IR fibers in the ganglion cell axon layer. Scale bar, 30 μm.
Figure 4.
 
Photomicrographs of retinal sections cut in a plane parallel to the vitreal surface and treated with the avidin-biotin-peroxidase technique. (A) shows large (arrow) and small (arrowhead) sst1-IR somata in the INL. Processes of these cells are not visible because the section was cut through the INL with no IPL portions included. (B) Large and small immunolabeled somata in the GCL with immunolabeled proximal portions of primary processes and bundles of sst1-IR fibers in the ganglion cell axon layer. Scale bar, 30 μm.
Figure 5.
 
Photomicrographs at two depths of a wholemounted retina treated with the avidin-biotin-peroxidase technique showing an immunolabeled displaced amacrine cell with processes that arborize in laminae 1 (A) and 5 (B) of the IPL and the cell body located in the GCL (B). Scale bar, 30 μm. (C) Densities (expressed as number of cells per square millimeter of retinal area) of sst1-expressing displaced amacrine cells measured at different eccentricities of the ventral retina. Left: Three wholemounted retinas used for analysis. Open, shaded, and filled circles: Retinal locations in the visual streak, in the midperipheral retina and at the ventral retinal edge, respectively, where analysis was performed. Values in the graph are the means ± SEM of cell densities measured in the three retinas at corresponding eccentricities. The highest density of sst1-containing displaced amacrine cells is observed at the ventral retinal edge.
Figure 5.
 
Photomicrographs at two depths of a wholemounted retina treated with the avidin-biotin-peroxidase technique showing an immunolabeled displaced amacrine cell with processes that arborize in laminae 1 (A) and 5 (B) of the IPL and the cell body located in the GCL (B). Scale bar, 30 μm. (C) Densities (expressed as number of cells per square millimeter of retinal area) of sst1-expressing displaced amacrine cells measured at different eccentricities of the ventral retina. Left: Three wholemounted retinas used for analysis. Open, shaded, and filled circles: Retinal locations in the visual streak, in the midperipheral retina and at the ventral retinal edge, respectively, where analysis was performed. Values in the graph are the means ± SEM of cell densities measured in the three retinas at corresponding eccentricities. The highest density of sst1-containing displaced amacrine cells is observed at the ventral retinal edge.
Figure 6.
 
Confocal images showing optical sections (1 μm thick) through the soma (A, C) and through the proximal portion of process arborization (B, D) of an amacrine cell double labeled with antibodies directed to sst1 and TH. sst1 immunoreactivity was visualized with Cy3-conjugated secondary antibodies (A, B), whereas TH immunoreactivity was visualized with FITC-conjugated secondary antibodies (C, D). In the cell body sst1 was on the plasma membrane, whereas TH was in the cytoplasm. Complete colocalization of sst1 and TH immunoreactivities was observed both in the soma and in the processes. Scale bar, 25 μm.
Figure 6.
 
Confocal images showing optical sections (1 μm thick) through the soma (A, C) and through the proximal portion of process arborization (B, D) of an amacrine cell double labeled with antibodies directed to sst1 and TH. sst1 immunoreactivity was visualized with Cy3-conjugated secondary antibodies (A, B), whereas TH immunoreactivity was visualized with FITC-conjugated secondary antibodies (C, D). In the cell body sst1 was on the plasma membrane, whereas TH was in the cytoplasm. Complete colocalization of sst1 and TH immunoreactivities was observed both in the soma and in the processes. Scale bar, 25 μm.
Figure 7.
 
Confocal images (1 μm thick) through sections cut in a plane parallel to the vitreal surface and double labeled with sst1 (A) and PV (C) antibodies or with sst1 (B) and GABA (D) antibodies. sst1 immunoreactivity was visualized with Cy3-conjugated secondary antibodies (A, B), whereas PV (C) and GABA (D) immunoreactivities were visualized with FITC-conjugated secondary antibodies. In these optical sections, sst1 immunolabeling was visible in amacrine cell somata in the innermost INL and in varicose fibers located in the most distal portion of lamina 1 of the IPL (A, B). PV- and GABA-IR cells did not express sst1 immunoreactivity. Scale bar, 25 μm.
Figure 7.
 
Confocal images (1 μm thick) through sections cut in a plane parallel to the vitreal surface and double labeled with sst1 (A) and PV (C) antibodies or with sst1 (B) and GABA (D) antibodies. sst1 immunoreactivity was visualized with Cy3-conjugated secondary antibodies (A, B), whereas PV (C) and GABA (D) immunoreactivities were visualized with FITC-conjugated secondary antibodies. In these optical sections, sst1 immunolabeling was visible in amacrine cell somata in the innermost INL and in varicose fibers located in the most distal portion of lamina 1 of the IPL (A, B). PV- and GABA-IR cells did not express sst1 immunoreactivity. Scale bar, 25 μm.
Figure 8.
 
Confocal images showing sections cut in a plane parallel to the vitreal surface and double labeled with sst1 (A) and SRIF (B) antibodies. In the ventral retina, all sst1-IR displaced amacrines, as visualized with Cy3-conjugated secondary antibodies (A), also display SRIF immunoreactivity, as visualized with FITC-conjugated secondary antibodies (B), both in the cell body and in the processes. Scale bar, 20 μm.
Figure 8.
 
Confocal images showing sections cut in a plane parallel to the vitreal surface and double labeled with sst1 (A) and SRIF (B) antibodies. In the ventral retina, all sst1-IR displaced amacrines, as visualized with Cy3-conjugated secondary antibodies (A), also display SRIF immunoreactivity, as visualized with FITC-conjugated secondary antibodies (B), both in the cell body and in the processes. Scale bar, 20 μm.
Epelbaum J, Dournaud P, Fodor M, Viollet C. The neurobiology of somatostatin. Crit Rev Neurobiol. 1994;8:25–44. [PubMed]
Reichlin S. Somatostatin. Krieger DT Brownstein MJ Martin JB eds. Brain Peptides. 1983;711–752. Wiley New York.
Hoyer D, Bell GI, Berlowitz M, et al. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci. 1995;16:86–88. [CrossRef] [PubMed]
Meyerhof W. The elucidation of somatostatin receptor functions: a current view. Rev Physiol Biochem Pharmacol. 1998;133:55–108. [PubMed]
Lanneau C, Bluet–Pajot MT, Zizzari P, et al. Involvement of the Sst1 somatostatin receptor subtype in the intrahypothalamic neuronal network regulating growth hormone secretion: an in vitro and in vivo antisense study. Endocrinology. 2000;141:967–979. [PubMed]
Helboe L, Stidsen CE, Moller M. Immunohistochemical and cytochemical localization of the somatostatin receptor subtype SST1 in the somatostatinergic parvocellular neuronal system of the rat hypothalamus. J Neurosci. 1998;18:4938–4945. [PubMed]
Lanneau C, Viollet C, Faivre–Bauman A, et al. Somatostatin receptor subtypes sst1 and sst2 elicit opposite effects on the response to glutamate of mouse hypothalamic neurones: an electrophysiological and single cell RT-PCR study. Eur J Neurosci. 1998;10:204–212. [CrossRef] [PubMed]
Petrucci C, Cervia D, Buzzi M, Biondi C, Bagnoli P. Somatostatin-induced control of cytosolic free calcium in pituitary tumor cells. Br J Pharmacol. 2000;129:471–484. [CrossRef] [PubMed]
Jen PY, Li WW, Yew DT. Immunohistochemical localization of neuropeptide Y and somatostatin in human fetal retina. Neuroscience. 1994;60:727–735. [CrossRef] [PubMed]
Watt CB, Florack VJ. A triple-label analysis demonstrating that enkephalin-, somatostatin- and neurotensin-like immunoreactivities are expressed by a single population of amacrine cells in the chicken retina. Brain Res. 1994;634:310–316. [CrossRef] [PubMed]
Engelmann R, Peichl L. Unique distribution of somatostatin-immunoreactive cells in the retina of the tree shrew (Tupaia belangeri). Eur J Neurosci. 1996;8:220–228. [CrossRef] [PubMed]
Rickman DW, Blanks JC, Brecha NC. Somatostatin-immunoreactive neurons in the adult rabbit retina. J Comp Neurol. 1996;365:491–503. [CrossRef] [PubMed]
Lugo N, Blanco RE. Somatostatin-like immunoreactive cells in the ground squirrel retina. Cell Biol Int. 1997;21:447–453. [CrossRef] [PubMed]
Sagar SM, Marshall PE, Onesti ST, Landis DMD. Somatostatin immunocytochemistry in the rabbit retina. Invest Ophthalmol Vis Sci. 1986;27:316–322. [PubMed]
Sagar SM. Somatostatin-like immunoreactive material in the rabbit retina: immunohistochemical staining using monoclonal antibodies. J Comp Neurol. 1987;266:291–299. [CrossRef] [PubMed]
Rickman DW, Brecha NC. Morphologies of somatostatin-immunoreactive neurons in the rabbit retina. Weiler R Osborne N eds. Neurobiology of the Inner Retina. 1989;461–468. Springer–Verlag New York.
Zalutsky RA, Miller RF. The physiology of somatostatin in the rabbit retina. J Neurosci. 1990;10:383–393. [PubMed]
Feigenspan A, Bormann J. Facilitation of GABAergic signaling in the retina by receptors stimulating adenylate cyclase. Proc Natl Acad Sci USA. 1994;91:10893–10897. [CrossRef] [PubMed]
Morgan IG, Boelen MK. A retinal dark-light switch: a review of the evidence. Vis Neurosci. 1996;13:399–409. [CrossRef] [PubMed]
Firth SI, Boelen MK, Morgan IG. Enkephalin, neurotensin and somatostatin increase cAMP levels in the chicken retina. Aust N Z J Ophthalmol. 1998;26((suppl) 1)S65–S67. [CrossRef] [PubMed]
Johnson J, Wong H, Walsh JH, Brecha NC. Expression of the somatostatin subtype 2A receptor in the rabbit retina. J Comp Neurol. 1998;393:93–101. [CrossRef] [PubMed]
Fontanesi G, Gargini C, Bagnoli P. Expression of somatostatin receptor subtype 2A (SST2A) the postnatal rabbit retina and its regulation. Soc Neurosci Abstr. 1998;24:1775.
Helboe L, Moller M. Immunohistochemical localization of somatostatin receptor subtypes sst1 and sst2 in the rat retina. Invest Ophthalmol Vis Sci. 1999;40:2376–2382. [PubMed]
Johnson J, Wu V, Wong H, Walsh JH, Brecha NC. Somatostatin receptor subtype 2A expression in the rat retina. Neuroscience. 1999;94:675–683. [CrossRef] [PubMed]
Mahony MC, Swanlund DJ, Billeter M, Roberts KP, Pryor JL. Regional distribution of 5alpha-reductase type 1 and type 2 mRNA along the human epididymis. Fertil Steril. 1998;69:1116–1121. [CrossRef] [PubMed]
Zhong H, Simons JW. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem Biophys Res Commun. 1999;259:523–526. [CrossRef] [PubMed]
Viollet C, Faivre–Bauman A, Zhang J, et al. Differential expression of somatostatin receptors by quantitative PCR in the rat brain. C R Acad Sci III. 1995;318:851–857. [PubMed]
Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract and kidney. Proc Natl Acad Sci USA. 1992;89:251–255. [CrossRef] [PubMed]
Yasuda K, Rens–Domiano S, Breder CD, et al. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenyl cyclase. J Biol Chem. 1992;267:20422–20428. [PubMed]
Schwabe W, Brennan MB, Hochgeschwender U. Isolation and characterization of the mouse (Musmusculus) somatostatin receptor type-4-encoding gene (mSSTR4). Gene. 1996;168:233–235. [CrossRef] [PubMed]
Baumeister H, Kreuzer OJ, Roosterman D, Schafer J, Meyerhof W. Cloning, expression, pharmacology and tissue distribution of the mouse somatostatin receptor subtype 5. J Neuroendocrinol. 1998;10:283–290. [PubMed]
Hasel KW, Glass JR, Godbout M, Sutcliffe J. G. An endoplasmic reticulum-specific cyclophilin. Mol Cell Biol.. 1991;11:3484–3491.
Helboe L, Moller M, Norregaard L, Schiodt M, Stidsen CE. Development of selective antibodies against the human somatostatin receptor subtypes SST1-SST5. Mol Brain Res. 1997;49:82–88. [CrossRef] [PubMed]
Casini G, Brecha NC. Postnatal development of tyrosine hydroxylase immunoreactive amacrine cells in the rabbit retina: II. Quantitative analysis. J Comp Neurol.. 1992;326:302–313. [CrossRef]
Casini G, Rickman DW, Brecha NC. AII amacrine cell population in the rabbit retina: identification by parvalbumin immunoreactivity. J Comp Neurol. 1995;356:132–142. [CrossRef] [PubMed]
Goehler LE, Sternini C, Brecha NC. Calcitonin gene-related peptide immunoreactivity in the biliary pathway and liver of the guinea pig: distribution and colocalization with substance P. Cell Tissue Res. 1988;253:145–150. [PubMed]
Masland RH, Rizzo JF, Sandell JH. Developmental variation in the structure of the retina. J Neurosci. 1993;13:5194–5202. [PubMed]
Casini G, Grassi A, Trasarti L, Bagnoli P. Developmental expression of protein kinase C immunoreactivity in rod bipolar cells of the rabbit retina. Vis. Neurosci.. 1996;13:817–831. [CrossRef] [PubMed]
Stone J. The wholemount handbook. 1981; Sydney, Australia: Maitland Press
Cajal SR. La rétine des vertébrés. Céllule. 1893;9:119–257.
Brecha NC, Oyster W, Takahashi ES. Identification and characterization of tyrosine hydroxylase immunoreactive amacrine cells. Invest Ophthalmol Vis Sci. 1984;25:66–70. [PubMed]
Hokoc JN, Mariani AP. Synapses from bipolar cells onto dopaminergic amacrine cells in cat and rabbit retinas. Brain Res. 1988;461:17–26. [CrossRef] [PubMed]
Mitrofanis J, Vigny A, Stone J. Distribution of catecholaminergic cells in the retina of the rat, guinea pig, cat, and rabbit: independence from ganglion cell distribution. J Comp Neurol. 1988;267:1–14. [CrossRef] [PubMed]
Versaux–Botteri C, Simon A, Vigny A, Nguyen–Legros J. Existence of immunoreactivity to GABA in dopaminergic amacrine cells of the rat retina. C R Acad Sci III. 1987;305:381–386. [PubMed]
Young HM. Co-localization of GABA- and tyrosine hydroxylase-like immunoreactivities in amacrine cells of the rabbit retina. Vision Res. 1994;34:995–999. [CrossRef] [PubMed]
Reisine T, Bell GI. Molecular biology of somatostatin receptors. Endocr Rev. 1995;16:427–442. [PubMed]
Schindler M, Humprey PPA, Emson PC. Somatostatin receptors in the central nervous system. Prog Neurobiol. 1995;50:9–47.
Corleto VD, Weber HC, Jensen RT. Expression of somatostatin receptor subtypes on guinea pig gastric and colonic smooth muscle cells. Am J Physiol. 1999;277:G235–G244. [PubMed]
Mori M, Aihara M, Shimizu T. Differential expression of somatostatin receptors in the rat eye: SSTR4 is intensely expressed in the iris/ciliary body. Neurosci Lett. 1997;223:185–188. [CrossRef] [PubMed]
Strettoi E, Masland RH. The number of unidentified amacrine cells in the mammalian retina. Proc Natl Acad Sci USA. 1996;93:14906–14911. [CrossRef] [PubMed]
Ayoub GS, Matthews G. Substance P modulates calcium current in retinal bipolar neurons. Vis Neurosci. 1992;8:539–544. [CrossRef] [PubMed]
Johnson J, Caravelli M, Brecha NC. Somatostatin inhibits Ca2+ influx into rat rod bipolar cells axonal terminals. Soc Neurosci Abs. 1999;25:1432.
Akopian A, Johnson J, Gabriel R, Brecha N, Witkovsky . Somatostatin modulates voltage-gated K+ and Ca2+ currents in rod and cone photoreceptors of the salamander retina. J Neurosci.. 2000;20:929–936. [PubMed]
Hathway GJ, Emson PC, Humphrey PP, Kendrick KM. Somatostatin potently stimulates in vivo striatal dopamine and gamma-aminobutyric acid release by a glutamate-dependent action. J Neurochem. 1998;70:1740–1749. [PubMed]
Hathway GJ, Humphrey PP, Kendrick KM. Evidence that somatostatin sst2 receptors mediate striatal dopamine release. Br J Pharmacol. 1999;128:1346–1352. [CrossRef] [PubMed]
Djamgoz MB, Wagner HJ. Localization and function of dopamine in the adult vertebrate retina. Neurochem Int. 1992;20:139–191. [CrossRef] [PubMed]
Larsen JN. Somatostatin in the retina. Acta Ophthalmol Scand Suppl. 1995;218:1–24. [PubMed]
Sagar SM, Rorstad OP, Landis DM, Arnold MA, Martin JB. Somatostatin-like immunoreactive material in the rabbit retina. Brain Res. 1982;244:91–99. [CrossRef] [PubMed]
Kossut M, Yamada T, Aldrich LB, Pinto LH. Localization and characterization of somatostatin binding sites in the mouse retina. Brain Res. 1989;476:78–84. [CrossRef] [PubMed]
Figure 1.
 
(A) RT-PCR products in homogenates from rabbit retinas (lanes a) and from mouse pituitary (lanes b, positive controls). Mouse subtype-specific primers yielded products with identical molecular weights, corresponding to sst1 to sst5, in rabbit retinas and in mouse pituitary (66 bp for sst1, 78 bp for sst2, 87 bp for sst3, 69 bp for sst4, and 363 bp for sst5). Lane MW: Molecular weight markers. (B) Levels of SRIF receptor mRNAs in rabbit retinas as evaluated by RT-PCR semiquantitative analysis. Each histogram represents the mean ± SEM (n = 6) of SRIF receptor mRNA levels expressed as percentages of the cyclophilin B mRNA level.
Figure 1.
 
(A) RT-PCR products in homogenates from rabbit retinas (lanes a) and from mouse pituitary (lanes b, positive controls). Mouse subtype-specific primers yielded products with identical molecular weights, corresponding to sst1 to sst5, in rabbit retinas and in mouse pituitary (66 bp for sst1, 78 bp for sst2, 87 bp for sst3, 69 bp for sst4, and 363 bp for sst5). Lane MW: Molecular weight markers. (B) Levels of SRIF receptor mRNAs in rabbit retinas as evaluated by RT-PCR semiquantitative analysis. Each histogram represents the mean ± SEM (n = 6) of SRIF receptor mRNA levels expressed as percentages of the cyclophilin B mRNA level.
Figure 2.
 
sst1 immunostaining pattern in cryostat sections cut in a plane perpendicular to the vitreal surface and stained with the avidin-biotin peroxidase technique. (A, B) Most sst1-IR somata were located in the INL adjacent to the IPL. In addition, some sst1-IR cell bodies of either small or large size (B) were observed in the GCL. Dense immunolabeling is observed in the IPL. Light, unspecific immunolabeling is present in rare cell bodies in the distal INL and in the OPL. Scale bar, 20 μm.
Figure 2.
 
sst1 immunostaining pattern in cryostat sections cut in a plane perpendicular to the vitreal surface and stained with the avidin-biotin peroxidase technique. (A, B) Most sst1-IR somata were located in the INL adjacent to the IPL. In addition, some sst1-IR cell bodies of either small or large size (B) were observed in the GCL. Dense immunolabeling is observed in the IPL. Light, unspecific immunolabeling is present in rare cell bodies in the distal INL and in the OPL. Scale bar, 20 μm.
Figure 3.
 
Confocal images (0.5 μm thick) through sections cut in a plane perpendicular to the vitreal surface showing sst1 immunoreactivity as visualized with Cy3-conjugated secondary antibodies. Immunostained cell bodies were localized in the proximal INL (A) and in the GCL (B). Note the localization of sst1 immunoreactivity to the plasma membrane of the cell bodies and to processes confined to laminae 1, 3, and 5 (A) or to laminae 1 and 5 of the IPL (B). Scale bar, 30 μm.
Figure 3.
 
Confocal images (0.5 μm thick) through sections cut in a plane perpendicular to the vitreal surface showing sst1 immunoreactivity as visualized with Cy3-conjugated secondary antibodies. Immunostained cell bodies were localized in the proximal INL (A) and in the GCL (B). Note the localization of sst1 immunoreactivity to the plasma membrane of the cell bodies and to processes confined to laminae 1, 3, and 5 (A) or to laminae 1 and 5 of the IPL (B). Scale bar, 30 μm.
Figure 4.
 
Photomicrographs of retinal sections cut in a plane parallel to the vitreal surface and treated with the avidin-biotin-peroxidase technique. (A) shows large (arrow) and small (arrowhead) sst1-IR somata in the INL. Processes of these cells are not visible because the section was cut through the INL with no IPL portions included. (B) Large and small immunolabeled somata in the GCL with immunolabeled proximal portions of primary processes and bundles of sst1-IR fibers in the ganglion cell axon layer. Scale bar, 30 μm.
Figure 4.
 
Photomicrographs of retinal sections cut in a plane parallel to the vitreal surface and treated with the avidin-biotin-peroxidase technique. (A) shows large (arrow) and small (arrowhead) sst1-IR somata in the INL. Processes of these cells are not visible because the section was cut through the INL with no IPL portions included. (B) Large and small immunolabeled somata in the GCL with immunolabeled proximal portions of primary processes and bundles of sst1-IR fibers in the ganglion cell axon layer. Scale bar, 30 μm.
Figure 5.
 
Photomicrographs at two depths of a wholemounted retina treated with the avidin-biotin-peroxidase technique showing an immunolabeled displaced amacrine cell with processes that arborize in laminae 1 (A) and 5 (B) of the IPL and the cell body located in the GCL (B). Scale bar, 30 μm. (C) Densities (expressed as number of cells per square millimeter of retinal area) of sst1-expressing displaced amacrine cells measured at different eccentricities of the ventral retina. Left: Three wholemounted retinas used for analysis. Open, shaded, and filled circles: Retinal locations in the visual streak, in the midperipheral retina and at the ventral retinal edge, respectively, where analysis was performed. Values in the graph are the means ± SEM of cell densities measured in the three retinas at corresponding eccentricities. The highest density of sst1-containing displaced amacrine cells is observed at the ventral retinal edge.
Figure 5.
 
Photomicrographs at two depths of a wholemounted retina treated with the avidin-biotin-peroxidase technique showing an immunolabeled displaced amacrine cell with processes that arborize in laminae 1 (A) and 5 (B) of the IPL and the cell body located in the GCL (B). Scale bar, 30 μm. (C) Densities (expressed as number of cells per square millimeter of retinal area) of sst1-expressing displaced amacrine cells measured at different eccentricities of the ventral retina. Left: Three wholemounted retinas used for analysis. Open, shaded, and filled circles: Retinal locations in the visual streak, in the midperipheral retina and at the ventral retinal edge, respectively, where analysis was performed. Values in the graph are the means ± SEM of cell densities measured in the three retinas at corresponding eccentricities. The highest density of sst1-containing displaced amacrine cells is observed at the ventral retinal edge.
Figure 6.
 
Confocal images showing optical sections (1 μm thick) through the soma (A, C) and through the proximal portion of process arborization (B, D) of an amacrine cell double labeled with antibodies directed to sst1 and TH. sst1 immunoreactivity was visualized with Cy3-conjugated secondary antibodies (A, B), whereas TH immunoreactivity was visualized with FITC-conjugated secondary antibodies (C, D). In the cell body sst1 was on the plasma membrane, whereas TH was in the cytoplasm. Complete colocalization of sst1 and TH immunoreactivities was observed both in the soma and in the processes. Scale bar, 25 μm.
Figure 6.
 
Confocal images showing optical sections (1 μm thick) through the soma (A, C) and through the proximal portion of process arborization (B, D) of an amacrine cell double labeled with antibodies directed to sst1 and TH. sst1 immunoreactivity was visualized with Cy3-conjugated secondary antibodies (A, B), whereas TH immunoreactivity was visualized with FITC-conjugated secondary antibodies (C, D). In the cell body sst1 was on the plasma membrane, whereas TH was in the cytoplasm. Complete colocalization of sst1 and TH immunoreactivities was observed both in the soma and in the processes. Scale bar, 25 μm.
Figure 7.
 
Confocal images (1 μm thick) through sections cut in a plane parallel to the vitreal surface and double labeled with sst1 (A) and PV (C) antibodies or with sst1 (B) and GABA (D) antibodies. sst1 immunoreactivity was visualized with Cy3-conjugated secondary antibodies (A, B), whereas PV (C) and GABA (D) immunoreactivities were visualized with FITC-conjugated secondary antibodies. In these optical sections, sst1 immunolabeling was visible in amacrine cell somata in the innermost INL and in varicose fibers located in the most distal portion of lamina 1 of the IPL (A, B). PV- and GABA-IR cells did not express sst1 immunoreactivity. Scale bar, 25 μm.
Figure 7.
 
Confocal images (1 μm thick) through sections cut in a plane parallel to the vitreal surface and double labeled with sst1 (A) and PV (C) antibodies or with sst1 (B) and GABA (D) antibodies. sst1 immunoreactivity was visualized with Cy3-conjugated secondary antibodies (A, B), whereas PV (C) and GABA (D) immunoreactivities were visualized with FITC-conjugated secondary antibodies. In these optical sections, sst1 immunolabeling was visible in amacrine cell somata in the innermost INL and in varicose fibers located in the most distal portion of lamina 1 of the IPL (A, B). PV- and GABA-IR cells did not express sst1 immunoreactivity. Scale bar, 25 μm.
Figure 8.
 
Confocal images showing sections cut in a plane parallel to the vitreal surface and double labeled with sst1 (A) and SRIF (B) antibodies. In the ventral retina, all sst1-IR displaced amacrines, as visualized with Cy3-conjugated secondary antibodies (A), also display SRIF immunoreactivity, as visualized with FITC-conjugated secondary antibodies (B), both in the cell body and in the processes. Scale bar, 20 μm.
Figure 8.
 
Confocal images showing sections cut in a plane parallel to the vitreal surface and double labeled with sst1 (A) and SRIF (B) antibodies. In the ventral retina, all sst1-IR displaced amacrines, as visualized with Cy3-conjugated secondary antibodies (A), also display SRIF immunoreactivity, as visualized with FITC-conjugated secondary antibodies (B), both in the cell body and in the processes. Scale bar, 20 μm.
Table 1.
 
Primers Used for Amplification
Table 1.
 
Primers Used for Amplification
Sense primers
sst1 (M1i) CAAGACGACGCCACCGTGAGCCA 28
sst2 (M2i) ATCAGCCCCACCCCAGCCCTGAA 28
sst3 (M3i) GTGTGCCCGCTGCCGGAGGAGCC 29
sst4 (M4i) ACCAGCCTCGATGCCACTGTCAA 30
sst5 (M5) GGGCTGGGGCACCTGCAACCTGA 27 31
Cyclophilin B CCATCGTGTCATCAAGGACTTCAT 32
Reverse primers
COM2 GGGGTTGGCACAGCTGTTG 27
Cyclophilin B TTGCCATCCAGCCAGGAGGTCT 32
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×